Back to Agenda
TOPIC 3 SESSION 2 CONTINUED: Drug-Induced Liver Injury
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert, GLD, France
Drug-Induced Liver Injury
Have an account?